Ad
related to: anticancer research journal impact factor search engine images- Programs & Services
Helping Patients Get The Support
They So Desperately Deserve & Need.
- Give In Honor & Memorial
Honor A Loved One With A Donation.
Support Those Touched By Cancer.
- Become a Monthly Donor
Be Part Of The Next Breakthrough.
Your Recurring Gift Saves Lives.
- More Ways To Give
Other Ways You Can Contribute to
Finding Cures and Fighting Cancer.
- Programs & Services
Search results
Results From The WOW.Com Content Network
Anticancer Research was established in 1981 by John G. Delinassios. According to the Journal Citation Reports, the journal had a 2020 impact factor of 2.480 and 25,656 total cites. The 2020 rejection rate was 68%. According to Scimago, the journal belongs to the second quartile (Q2) in the "Medicine" category.
This is a list of open-access journals by field. The list contains notable journals which have a policy of full open access. It does not include delayed open access journals, hybrid open access journals, or related collections or indexing services.
The impact factor (IF) or journal impact factor (JIF) of an academic journal is a scientometric index calculated by Clarivate that reflects the yearly mean number of citations of articles published in the last two years in a given journal, as indexed by Clarivate's Web of Science.
Anti-Cancer Drugs is an international medical journal, which aims to promote and encourage research on anti-cancer agents. It was first published in 1990 and it includes reports on clinical and experimental research results, from conventional cytotoxic chemotherapy to hormonal or biological response modalities. [ 1 ]
The journal covers developments in "medicinal chemistry and rational drug design for the discovery of anti-cancer agents" and publishes original research reports and review papers. [1] It is related to the journal Current Medicinal Chemistry and was established in 2001 as Current Medicinal Chemistry – Anti-Cancer Agents. [2]
The values for Nature journals lie well above the expected ca. 1:1 linear dependence because those journals contain a significant fraction of editorials. CiteScore was designed to compete with the two-year JCR impact factor, which is currently the most widely used journal metric. [7] [8] Their main differences are as follows: [9]
Journal ranking is widely used in academic circles in the evaluation of an academic journal's impact and quality. Journal rankings are intended to reflect the place of a journal within its field, the relative difficulty of being published in that journal, and the prestige associated with it.
It is affiliated with the African Organization for Research and Training in Cancer. The editors-in-chief are Franco M. Buonaguro (Istituto Nazionale Tumori), Sam M. Mbulaiteye (National Cancer Institute) and Maria Lina Tornesello (Istituto Nazionale Tumori). According to the Journal Citation Reports, the journal has a 2021 impact factor of 3. ...